Our website uses cookies to make navigation as functional as possible. Our cookies do not enable us to identify you in any way. Should you wish to receive more information, or deny your consent to all or some of the cookies, please click here to disable them. By continuing to browse this site , you will be accepting our cookies.

News

The Menarini art series emboldened by the courage of Artemisia
Monograph presented at Palazzo Pitti for the Italian Renaissance’s most famous female artist
Menarini chooses Google Cloud for its digital transformation
The Menarini Group, a worldwide leader in the pharmaceutical industry, has chosen Google Cloud to help it work in a smarter and more flexible way, through the use of G Suite which will allow its 17,000 employees to work...
Menarini Ricerche to present the most recent pre-clinical data about the PI3K inhibitor MEN1611 at the AACR Annual Meeting 2018.
Menarini Ricerche  will present on the latest preclinical studies of its phosphatidylinositol 3-kinase (PI3K) class I inhibitor MEN1611, in development for solid tumors, at the AACR Annual Meeting 2018, which will take pla...
MENARINI ANNOUNCES NEW GOVERNANCE
Pharmaceutical group Menarini, headed by the Aleotti family, has decided to entrust the  Chairmanship of the company  to an external manager coming from a large multinational,  Dr. Eric Cornut.  The new chairmanship will...
Menarini Ricerche attended the Brainstorming Meeting on CD38 and CD157 which was held on September 21st-23rd 2017 at San Benedetto Po and Mantova (Ita
Menarini Ricerche was invited to present an update on MEN1112, a humanized monoclonal antibody targeting CD157, which is co-developed with Oxford BioTherapeutics for the treatment of acute myeloid leukemia (AML)
Oncology Research: new opportunities for Menarini and OBT
Oncology Alliance between Menarini & Oxford BioTherapeutics Progresses Second Candidate MEN1309 into the Clinic, an Antibody Drug Conjugate for the treatment of solid tumors and NHL

Quality first


Quality: point of departure and arrival for our drugs.

READ MORE »

Menarini in the world

The Menarini Group has companies located almost all over the world.

READ MORE »

Innovation & Research

Constant commitment to new drug research.

READ MORE »

Our values

 

10 core values have influenced the progress of our group.

READ MORE »